GO:0015837 amine transport: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015837 (amine transport) describes the directed movement of amines, including polyamines and other organic compounds containing one or more amino groups, into, out of, or within a cell, or between cells, by means of a transporter or pore.
• Amine transport is essential for neurotransmitter storage and signaling, as exemplified by the vesicular and plasma membrane transport of serotonin and acetylcholine.
• Choline, a quaternary amine, is transported by multiple dedicated transporters for phospholipid synthesis and mitochondrial import, linking amine transport to membrane biogenesis and one-carbon metabolism.
• Polyamine transport systems in bacteria and yeast are critical for growth, stress resistance, and virulence, and are increasingly studied as drug targets.
• Dysregulation of amine transport is implicated in neurological disorders, cancer, and metabolic disease, making transporters attractive therapeutic targets.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable causal dissection of amine transporter function in human cells and animal models.
Description
Amine transport (GO:0015837) is a fundamental biological process that governs the movement of amines, including polyamines and other organic compounds containing one or more amino groups, across cellular membranes or within cells. This process is mediated by specialized transporters or pores and is essential for a wide range of physiological functions, from neurotransmitter storage and release to polyamine homeostasis and phospholipid synthesis. The term encompasses the directed movement of these molecules into, out of, or within a cell, or between cells, reflecting the diverse roles amines play in cellular metabolism and signaling. Researchers study amine transport to understand how cells acquire and distribute essential amines, how these processes are regulated, and how their dysfunction contributes to human disease. The identification of specific transporters, such as those for serotonin, choline, and polyamines, has revealed intricate mechanisms of substrate recognition, energy coupling, and regulation. Moreover, amine transport is critical for normal development and physiology, as highlighted by the requirement for choline transport in phospholipid synthesis and mitochondrial function. Given its broad impact, amine transport is a vibrant area of research with implications for neuroscience, cancer biology, and metabolic disorders.
amine transport At A Glance
| GO ID | GO:0015837 |
|---|---|
| GO term | amine transport |
| Ontology | biological_process |
| Synonym | amine/polyamine transport |
| Major function | Directed movement of amines, including polyamines, across membranes or within cells |
| Definition | The directed movement of amines, including polyamines, organic compounds containing one or more amino groups, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore |
| Related processes | Neurotransmitter transport, polyamine homeostasis, choline transport, phospholipid synthesis |
What Is GO:0015837?
According to the Gene Ontology, GO:0015837 (amine transport) is defined as the directed movement of amines, including polyamines, organic compounds containing one or more amino groups, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. This definition captures the essence of amine transport as an active or facilitated process that requires a protein machinery to move amine molecules across biological membranes or within cellular compartments. The term is synonymous with amine/polyamine transport and is classified under the biological_process aspect of the ontology.
Why Is amine transport Important in Cell Biology?
Amine transport is critically important because amines participate in numerous cellular processes, including neurotransmission, cell growth, and membrane synthesis, and their transport must be tightly regulated to maintain cellular homeostasis. Defects in amine transport are associated with a range of human diseases, from psychiatric and neurodegenerative disorders to cancer and metabolic syndromes, making transporters key targets for therapeutic intervention. Understanding the molecular mechanisms of amine transport can reveal new strategies for drug development and provide insights into fundamental cell biology.
• Amine transport is essential for neurotransmitter storage and release, impacting synaptic transmission and brain function.
• Polyamine transport is required for cell proliferation and stress responses in bacteria, yeast, and mammals.
• Choline transport supports phospholipid synthesis and mitochondrial metabolism, linking amine transport to membrane biogenesis and energy production.
• Dysregulated amine transport contributes to cancer progression, as polyamines and choline are needed for rapid cell growth.
• Transporters for amines are targets for drugs treating depression, Alzheimer's disease, and other neurological conditions.
• Genetic variants in amine transporters can cause metabolic disorders and are studied using CRISPR models.
• Amine transport systems in pathogens are potential antibiotic targets.
• Studying amine transport helps explain how cells adapt to nutrient availability and metabolic stress.
What Happens During amine transport?
Substrate recognition and binding
In simple terms: The transporter first grabs the amine molecule it needs to move.
Amine transporters exhibit specificity for their substrates, which can include polyamines, choline, serotonin, and other monoamines. For example, choline transporters recognize the quaternary amine choline through specific amino acid residues that form a binding pocket, as revealed by structural and kinetic studies. Similarly, serotonin transporters bind serotonin with high affinity, and this binding is coupled to ion gradients. Polyamine transporters in bacteria and yeast show preferences for different polyamines, such as putrescine, spermidine, and spermine, and their binding sites are adapted to the polycationic nature of these molecules. The initial recognition step is critical for ensuring that only appropriate amines are transported, and it often involves conformational changes in the transporter.
Translocation across the membrane
In simple terms: The transporter then moves the amine across the cell membrane.
After binding, the transporter undergoes conformational changes that allow the amine to pass through the membrane barrier. This translocation can occur via different mechanisms, including facilitated diffusion, secondary active transport, or vesicular transport. For instance, the vesicular acetylcholine transporter uses a proton gradient to drive acetylcholine into synaptic vesicles, while the serotonin transporter uses sodium and chloride gradients to move serotonin into cells. In the case of mitochondrial choline import, SLC25A48 mediates the transport of choline into mitochondria, a process essential for one-carbon metabolism. The energy source and coupling mechanism vary among transporters, but the outcome is the directed movement of the amine across a lipid bilayer.
Release and distribution within cells
In simple terms: Once inside, the amine is released to where it is needed.
Following translocation, the amine is released from the transporter and becomes available for cellular processes. For example, transported choline is used for phosphatidylcholine synthesis in the Kennedy pathway, and transported polyamines are distributed to sites of RNA binding and protein synthesis. In neurons, serotonin transported into cells can be packaged into vesicles for later release, while acetylcholine is stored in synaptic vesicles. The release step may involve additional transporters or channels, and it is often regulated by intracellular signals. Proper distribution ensures that amines fulfill their roles in metabolism, signaling, and structural integrity.
Regulation and adaptation
In simple terms: The cell can adjust how much amine it takes up based on its needs.
Amine transport is regulated at multiple levels, including transporter expression, post-translational modifications, and feedback inhibition. For instance, choline transporter-like protein 1 (CTL1) expression is regulated in response to choline availability and cellular demand for phospholipids. In mitochondria, SLC25A48-mediated choline import is necessary for optimal mitochondrial function and is subject to metabolic regulation. Polyamine transport in bacteria and yeast is controlled by antizyme and other regulatory proteins that respond to polyamine levels. Additionally, neurotransmitter transporters such as the serotonin transporter are regulated by phosphorylation and trafficking, which affect their surface expression and activity. This regulation allows cells to adapt to changing environments and maintain homeostasis.
Key Genes Involved in GO:0015837 amine transport
The following genes encode transporters and related proteins that mediate amine transport, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC6A4 | Serotonin transporter; reuptakes serotonin from synaptic cleft | Target of antidepressants; studied in mood disorders |
| SLC18A3 | Vesicular acetylcholine transporter; packages acetylcholine into vesicles | Essential for cholinergic neurotransmission |
| SLC5A7 | Choline transporter 1 (CHT1); high-affinity choline uptake for acetylcholine synthesis | Rate-limiting for acetylcholine production |
| SLC44A1 | Choline transporter-like protein 1 (CTL1); choline transport for phospholipid synthesis | Emerging role in membrane biogenesis |
| SLC25A48 | Mitochondrial choline importer | Necessary for mitochondrial choline import and one-carbon metabolism |
| FLVCR1 | Heme/choline transporter; involved in lipid head group entry to Kennedy pathway | Structural basis of choline transport |
| SLC22A1 | Organic cation transporter 1; transports monoamines and polyamines | Drug transport and polyamine homeostasis |
| SLC22A2 | Organic cation transporter 2; transports monoamines and polyamines | Renal and hepatic amine transport |
| SLC22A3 | Organic cation transporter 3; transports monoamines and polyamines | Broad substrate specificity |
| SLC7A1 | Cationic amino acid transporter; also transports polyamines | Polyamine uptake in mammalian cells |
| SLC3A2 | Heavy chain of amino acid transporters; associates with polyamine transport | Polyamine transport complex |
| ATP13A2 | Polyamine transporter; implicated in Parkinson's disease | Neurodegeneration and polyamine homeostasis |
| SLC18A1 | Vesicular monoamine transporter 1; transports monoamines into vesicles | Monoamine storage |
| SLC18A2 | Vesicular monoamine transporter 2; transports monoamines into vesicles | Monoamine storage and neurotransmission |
| SLC6A2 | Norepinephrine transporter; reuptakes norepinephrine | Neurotransmission and drug target |
| SLC6A3 | Dopamine transporter; reuptakes dopamine | Neurotransmission and addiction |
| SLC44A2 | Choline transporter-like protein 2; choline transport | Choline transport in various tissues |
| SLC44A4 | Choline transporter-like protein 4; choline transport | Choline transport and metabolism |
How Is amine transport Regulated?
Amine transport is regulated at multiple levels to meet cellular demands. Transcriptional regulation controls the expression of transporter genes in response to nutrient availability, hormones, and stress. For example, choline transporter-like protein 1 (CTL1) expression is modulated by choline availability and the need for phospholipid synthesis. Post-translational modifications, such as phosphorylation, regulate transporter trafficking and activity; the serotonin transporter is a well-studied example where phosphorylation affects its surface expression and reuptake capacity. In mitochondria, SLC25A48-mediated choline import is essential for one-carbon metabolism and is likely regulated by metabolic signals. Polyamine transport in bacteria and yeast is feedback-inhibited by excess polyamines through antizyme and other regulators. Additionally, vesicular transporters like VMAT and VAChT are regulated by proton gradients and vesicular pH. These regulatory mechanisms ensure that amine transport is coordinated with cellular metabolism and signaling.
amine transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC6A4 | Depression, anxiety, obsessive-compulsive disorder | Knockout mice, human iPSC-derived neurons |
| SLC18A2 | Parkinson's disease, monoamine imbalance | Knockout and knock-in mouse models |
| SLC25A48 | Metabolic disorders, mitochondrial dysfunction | CRISPR knockout in human cell lines |
| SLC44A1 | Choline deficiency, phospholipid disorders | Overexpression and knockout in cell lines |
| ATP13A2 | Kufor-Rakeb syndrome, Parkinson's disease | Patient-derived neurons, knockout models |
Neurological and psychiatric disorders
Alterations in amine transport are linked to neurological and psychiatric conditions. The serotonin transporter (SLC6A4) is a primary target of selective serotonin reuptake inhibitors (SSRIs) used to treat depression and anxiety, and its dysfunction is implicated in mood disorders. Vesicular monoamine transporters (VMAT1 and VMAT2) are involved in packaging monoamines into synaptic vesicles, and their dysfunction can lead to monoamine imbalances associated with Parkinson's disease and other neurodegenerative disorders. Choline transport is also critical for acetylcholine synthesis, and reduced choline uptake may contribute to cognitive decline in Alzheimer's disease. These examples highlight the importance of amine transport in maintaining normal brain function.
Cancer and metabolic reprogramming
Cancer cells often exhibit increased demand for amines, particularly polyamines and choline, to support rapid proliferation and membrane synthesis. Upregulation of polyamine transport is observed in many cancers, and targeting these transporters is a potential therapeutic strategy. Choline transport, mediated by transporters such as CTL1 and SLC25A48, supports phospholipid synthesis and mitochondrial metabolism, which are essential for tumor growth. The structural and functional characterization of choline transporters like FLVCR1 provides insights into how cancer cells acquire choline for the Kennedy pathway. Thus, amine transport is a key metabolic vulnerability in cancer.
Infectious diseases and microbial pathogenesis
Polyamine transport systems in bacteria and yeast are essential for growth and virulence, making them attractive targets for antimicrobial therapy. For example, pathogenic bacteria rely on polyamine uptake to resist host defenses and to form biofilms. Understanding the molecular mechanisms of these transporters can inform the development of new antibiotics. Additionally, some parasites depend on amine transport for survival, and inhibitors of these transporters are being explored as antiparasitic drugs.
From amine transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of SLC25A48 impair mitochondrial choline import? | CRISPR knockout in HEK293T or HeLa cells |
| How does a point mutation in SLC6A4 affect serotonin transport? | Point-mutation knock-in in human cell lines |
| Can overexpression of CTL1 increase phospholipid synthesis? | Overexpression in CHO or HeLa cells |
| What is the effect of tagging SLC18A2 on vesicular monoamine transport? | Tagged knock-in in mouse neurons |
| Does knockout of polyamine transporters reduce cancer cell growth? | CRISPR knockout in cancer cell lines |
| How does FLVCR1 mediate choline transport structurally? | Knock-in with fluorescent tag and structural studies |
How to Study the amine transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled uptake assay | Transport activity and kinetics | Characterizing serotonin or choline transporters |
| Cryo-EM | High-resolution structure of transporters | Understanding substrate binding and conformational changes |
| CRISPR knockout | Loss-of-function phenotype | Testing necessity of transporters in cells |
| RNA-seq | Gene expression changes | Identifying compensatory or regulated transporters |
| Metabolomics | Metabolite levels and flux | Linking transport to phospholipid synthesis |
| Live-cell imaging | Transporter localization and dynamics | Studying trafficking and regulation |
| Site-directed mutagenesis | Functional role of specific residues | Mapping substrate binding sites |
| Proteomics | Protein expression and interactions | Identifying transporter complexes |
Transport assays
Radiolabeled or fluorescent amine substrates are used to measure transport activity in cells or membrane vesicles. For example, uptake of radiolabeled serotonin or choline can be quantified to assess transporter function. These assays are often performed with specific inhibitors to distinguish between different transporters. Kinetic analyses yield Km and Vmax values that characterize transporter affinity and capacity.
Structural biology and imaging
Cryo-electron microscopy and X-ray crystallography have provided high-resolution structures of amine transporters, revealing substrate binding sites and conformational changes. Fluorescence microscopy and live-cell imaging allow visualization of transporter localization and trafficking in real time. These methods are complemented by mutagenesis to test the roles of specific residues.
Genetic and genomic approaches
CRISPR-Cas9 knockout, point mutations, and knock-in of tags or reporters enable functional studies of amine transporters in cells and animal models. RNA sequencing and proteomics can reveal changes in transporter expression and downstream metabolic pathways. Genome-wide screens, such as GeneMAP, have identified new genes required for mitochondrial choline import.
Metabolic and flux analysis
Stable isotope tracing and metabolomics measure the incorporation of transported amines into downstream metabolites, such as phosphatidylcholine from choline. These methods link transport activity to metabolic flux and cellular function. They are particularly useful for studying choline and polyamine metabolism.
How CRISPR Can Be Used to Study GO:0015837 amine transport
Knockout
CRISPR knockout of amine transporter genes, such as SLC25A48 or SLC44A1, allows researchers to assess their essentiality for cellular uptake and downstream metabolism. Knockout cell lines can be used to measure changes in choline or polyamine levels and to test compensatory mechanisms. In vivo knockout models, such as mice lacking SLC6A4, provide insights into behavior and disease.
Point Mutation
Introducing specific point mutations into transporter genes via CRISPR can mimic human genetic variants and reveal how single amino acid changes affect substrate binding, transport kinetics, or regulation. For example, mutations in the serotonin transporter linked to psychiatric disorders can be modeled in cell lines to study their functional impact. Point mutations in choline transporters can help map the substrate binding pocket.
Knock-in
Knock-in of tags, such as fluorescent proteins or epitope tags, enables visualization and purification of amine transporters. Tagged knock-in models can be used to track transporter localization and dynamics in live cells. Additionally, knock-in of disease-associated mutations provides more physiologically relevant models than overexpression.
Overexpression
Overexpression of amine transporters in cell lines, such as HEK293 or CHO cells, is widely used to study transport activity, substrate specificity, and inhibitor sensitivity. Overexpression can also rescue loss-of-function phenotypes and help identify downstream effects. However, careful controls are needed to avoid artifacts from supraphysiological expression.
How EDITGENE Supports amine transport Research
Researchers studying amine transport-related genes often need to determine whether a candidate gene is causally involved in amine uptake, metabolism, or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to create precisely engineered cell models, enabling functional validation of amine transporters and related proteins.
Contact EDITGENE today to design your custom CRISPR model for amine transport research.
Frequently Asked Questions About amine transport
What is GO:0015837?
GO:0015837 is the Gene Ontology term for amine transport, defined as the directed movement of amines, including polyamines, into, out of or within a cell, or between cells, by means of a transporter or pore.
What genes are involved in amine transport?
Genes encoding amine transporters include SLC6A4 (serotonin transporter), SLC18A3 (vesicular acetylcholine transporter), SLC5A7 (choline transporter 1), SLC44A1 (CTL1), SLC25A48 (mitochondrial choline importer), and many others.
How is amine transport studied?
Amine transport is studied using radiolabeled uptake assays, structural biology, CRISPR knockout and knock-in models, and metabolomics to measure transport activity and downstream effects.
Why is amine transport important for health?
Amine transport is crucial for neurotransmission, polyamine homeostasis, phospholipid synthesis, and mitochondrial metabolism; its dysfunction is linked to neurological disorders, cancer, and metabolic diseases.
What diseases are associated with amine transport defects?
Diseases include depression and anxiety (serotonin transporter), Parkinson's disease (VMAT2, ATP13A2), cancer (polyamine and choline transporters), and metabolic disorders (SLC25A48).
What is the role of choline transport in cells?
Choline transport supplies choline for phosphatidylcholine synthesis via the Kennedy pathway and for mitochondrial one-carbon metabolism, and it is mediated by transporters such as CTL1 and SLC25A48.
How do polyamines get into cells?
Polyamines enter cells through dedicated transporters, such as those in the SLC22 and SLC7 families, and their uptake is regulated by feedback mechanisms involving antizyme.
Can CRISPR be used to study amine transporters?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models allow precise functional dissection of amine transporters in human cells and animal models.
What is the vesicular acetylcholine transporter?
The vesicular acetylcholine transporter (VAChT, encoded by SLC18A3) packages acetylcholine into synaptic vesicles using a proton gradient, which is essential for cholinergic neurotransmission.
What is the mitochondrial choline importer?
SLC25A48 is a mitochondrial choline importer necessary for mitochondrial choline uptake and one-carbon metabolism, as identified by the GeneMAP platform.
Conclusion
Amine transport (GO:0015837) is a vital biological process that ensures the proper distribution of amines, including polyamines and choline, across cellular membranes. It underpins neurotransmission, membrane synthesis, mitochondrial metabolism, and cell growth, and its dysregulation contributes to a spectrum of human diseases. Advances in structural biology, CRISPR genome editing, and metabolic profiling continue to illuminate the molecular mechanisms and regulatory networks of amine transporters. Targeting these transporters holds promise for therapeutic development in neurology, oncology, and metabolic disorders. Continued research using precise cell models will further unravel the complexities of amine transport and its impact on health and disease.
References
- 1. Rudnick G et al.. 2019. Serotonin transport in the 21st century.. J Gen Physiol 151(11):1248-1264 PMID: 31570504
- 2. Son Y et al.. 2024. Structural basis of lipid head group entry to the Kennedy pathway by FLVCR1.. Nature 629(8012):710-716 PMID: 38693265
- 3. Michel V et al.. 2006. Choline transport for phospholipid synthesis.. Exp Biol Med (Maywood) 231(5):490-504 PMID: 16636297
- 4. Khan A et al.. 2024. Metabolic gene function discovery platform GeneMAP identifies SLC25A48 as necessary for mitochondrial choline import.. Nat Genet 56(8):1614-1623 PMID: 38977856
- 5. Redeker KM et al.. 2025. Diversity of human choline transporters: substrate specificity, kinetic properties, and inhibitor sensitivity.. Biochem Pharmacol 242(Pt 2):117343 PMID: 40972734
- 6. Igarashi K et al.. 1999. Polyamine transport in bacteria and yeast.. Biochem J 344 Pt 3(Pt 3):633-42 PMID: 10585849
- 7. Parsons SM. 2000. Transport mechanisms in acetylcholine and monoamine storage.. FASEB J 14(15):2423-34 PMID: 11099460
- 8. Hedtke V et al.. 2019. Choline transport for phospholipid synthesis: An emerging role of choline transporter-like protein 1.. Exp Biol Med (Maywood) 244(8):655-662 PMID: 30776907
